GEODE CAPITAL MANAGEMENT, LLC
Position in AUPH — Aurinia Pharmaceuticals Inc.
CIK 1214717
BOSTON, MA
Position in AUPH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$28,868,549
+$6,104,897 QoQ
Shares Held
1,701,152
+10.8% QoQ
Ownership
1.28%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 279 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. AUPH ranks #111 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in AUPH
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,868,549 | 1,701,152 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $22,763,652 | 1,536,009 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $24,050,510 | 1,507,869 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $16,416,984 | 1,485,700 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $13,357,697 | 1,577,060 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $13,943,771 | 1,734,300 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $15,844,266 | 1,764,395 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $12,947,491 | 1,766,370 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $10,070,166 | 1,763,602 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $8,031,430 | 1,603,080 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $14,106,532 | 1,569,136 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $11,560,159 | 1,487,794 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $13,656,214 | 1,410,766 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $14,564,239 | 1,328,854 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,395,481 | 1,248,954 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,061,464 | 1,204,982 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,693,808 | 1,163,563 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,387,760 | 112,097 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,391,858 | 104,585 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,724,424 | 123,110 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,802,282 | 139,065 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,660,456 | 127,875 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,749,481 | 126,499 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,707,545 | 115,923 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,590,972 | 97,906 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,392,423 | 95,963 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||